Compound-specific effects of diverse neurodevelopmental toxicants on global gene expression in the neural embryonic

P T Theunissen1, J F Robinson, J L A Pennings

  • 1Laboratory for Health Protection Research, National Institute for Public Health and Environment (RIVM), Bilthoven, The Netherlands. Peter.Theunissen@rivm.nl

Insights

This study shows that transcriptomics can identify toxic concentrations in developmental toxicity testing using the neural stem cell test (ESTn). Gene expression changes reveal compound-specific effects and concentration-dependent toxicity, aiding alternative testing strategies.

Area of Science:

  • Toxicology
  • Developmental Biology
  • Genomics

Background:

  • Reducing animal use in regulatory toxicology necessitates alternative testing methods.
  • The in vitro murine neural embryonic stem cell test (ESTn) is a promising alternative for neurodevelopmental toxicity assessment.
  • Integrating toxicogenomics can enhance predictivity and elucidate mechanisms of developmental toxicity.

Purpose of the Study:

  • To investigate the concentration-dependent effects of six diverse compounds on the ESTn transcriptome and neural differentiation.
  • To identify gene expression changes and associated biological processes affected by these compounds.
  • To assess the potential of transcriptomics for distinguishing toxic from non-toxic concentrations.

Main Methods:

  • Exposure of the ESTn to six compounds (acetaldehyde, carbamazepine, flusilazole, MEHP, penicillin G, phenytoin) at various concentrations.
  • Assessment of changes in cell morphology, neural differentiation, and cytotoxicity.
  • Transcriptomic analysis (gene expression profiling) after 24h exposure at equipotent differentiation-inhibiting concentrations.
  • Gene Ontology Biological Process (GO-BP) enrichment analysis.

Main Results:

  • Five out of six compounds altered ESTn morphology and neural differentiation in a concentration-dependent manner (penicillin G showed no effect).
  • Transcriptomic analysis revealed both compound-specific and common gene expression changes, with acetaldehyde, carbamazepine, and flusilazole inducing more robust changes than MEHP, phenytoin, and penicillin G.
  • Genes involved in embryonic morphogenesis, neuron differentiation, and Wnt signaling were differentially regulated by acetaldehyde, carbamazepine, and flusilazole.
  • Gene expression and GO-BP enrichment demonstrated concentration dependence, enabling discrimination between toxic and non-toxic concentrations.

Conclusions:

  • Transcriptomic profiling in the ESTn effectively captures concentration-dependent effects of developmental toxicants.
  • The study provides insights into the molecular mechanisms underlying neurodevelopmental toxicity for diverse compounds.
  • This approach supports the development of transcriptomics-based assays for regulatory developmental toxicity testing, reducing animal use.